Skip to main content

Table 3 IrAEs that lead to ICIs interruption

From: Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators

IrAE

N

Miositis

1

Diabetes mellitus

1

Ipofisitis

2

Nefritis

3

Pneumonitis

2

Injection reaction

2

Colitis

2

Neuro toxicities

2

Pancreatitis

3

Arthritis

1

Ocular toxicities

1

Hemolytic anemia

1

Hepatitis

2

  1. N: number; IrAE: immune-related adverse events; ICIs: immune checkpoint inhibitors
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us